Zorvolex FDA Approval History
Zorvolex (diclofenac) is a nonsteroidal anti-inflammatory drug (NSAID) indicated for the treatment of mild to moderate acute pain, and for the management of osteoarthritis pain.
Development timeline for Zorvolex
|Aug 25, 2014||Approval Iroko Pharmaceuticals Gains FDA Approval of Zorvolex for Management of Osteoarthritis Pain|
|Oct 18, 2013||Approval Iroko Pharmaceuticals Receives FDA Approval for Zorvolex|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.